WeTrials
Recruiting

Phase 1/2 Study of Rina-S in Patients With Locally Advanced and/or Metastatic Solid Tumors

What is this study?

This clinical trial is testing a new investigational drug called Rina-S, either alone or with other medicines, for people with advanced solid tumor cancers. The main goal is to check the safety and side effects of Rina-S to see how well it works for patients.

Who can participate?

You may be able to join if you have certain types of advanced or spreading cancers, such as ovarian, lung, breast, or uterine cancer, and have already tried standard treatments. Your tumors also need to be measurable on standard scans.

What will happen?

Participants will receive the study medication, Rina-S, and possibly other approved cancer treatments while being closely monitored by the medical team for side effects. You will have regular check-ups and scans to see how your body is responding to the treatment.

Where and when?

This study is currently recruiting participants and is taking place at medical centers in Phoenix and Tucson, Arizona, as well as Los Angeles, California.

Key Points
  • 1Tests a new anti-cancer drug called Rina-S for advanced solid tumors
  • 2Open to patients who have already tried standard treatments for specific cancers
  • 3Currently recruiting at locations in Arizona and California

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube CancerEndometrial CancerNon-small Cell Lung CancerEpidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC)MesotheliomaBreast AdenocarcinomaTriple Negative Breast CancerHormone Receptor-positive/Her2 Negative Breast CancerPlatinum-resistant Ovarian Cancer (PROC)Platinum Sensitive Ovarian Cancer (PSOC)Primary Refractory Ovarian CancerUterine Cancer

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.